Z-1099-2021 Class II Terminated
FDA device recall Z-1099-2021 was initiated by Cytocell Ltd. on Dec 22, 2020 and is designated Class II. Reason for recall: Users may observe very faint additional locus specific signals at 11q13. There is a low risk of a normal sample being reported as not normal in a resulting laboratory developed test (LDT) that… The recall status is terminated (terminated Jun 7, 2022). Affected quantity: 72.
Recall details
- Product Type
- Devices
- Report Date
- Feb 17, 2021
- Initiation Date
- Dec 22, 2020
- Termination Date
- Jun 7, 2022
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 72
Product description
Aquarius LPH 511-A CRLF2 Distal Probe Green, model no. LPH 511-A The CRLF2 Distal probe, labelled in green, consists of two probes (71kb and 131kb) that are situated distal (telomeric) to the CRLF2 gene
Reason for recall
Users may observe very faint additional locus specific signals at 11q13. There is a low risk of a normal sample being reported as not normal in a resulting laboratory developed test (LDT) that utilizes the LPH511-A CRLF2 Distal Probe Green.
Distribution pattern
Domestic distribution to California, Illinois, Michigan, Minnesota, New Jersey, Texas, and Washington. Foreign distribution to Canada.
Code information
Lots 072240, 071390, and 072693
Source
- Dataset
- openFDA device recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for Z-1099-2021
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026